| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,010 | 0,032 | 06.11. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.10. | Correction: The Board of Directors of Bioretec Ltd resolved on a new stock option plan | 2 | Cision News | ||
| 12.10. | Composition of Bioretec's Shareholders' Nomination Board | 1 | Cision News | ||
| 08.10. | Bioretec Oy: Inside information: Bioretec initiates change negotiations to improve operational efficiency and competitiveness | 260 | GlobeNewswire (Europe) | Bioretec Ltd, Inside Information, 8 October 2026 at 4:00 p.m. EEST
Bioretec Ltd will initiate change negotiations in accordance with the Co-operation Act as part of the development of the company's... ► Artikel lesen | |
| 05.09. | Bioretec Oy: Bioretec receives FDA 510(k) clearance for its ActivaScrew Cannulated COM bioabsorbable compression screw | 343 | GlobeNewswire (Europe) | Bioretec Ltd. | Inside information | 5 September 2026 at 12:25 p.m. EEST
Bioretec Ltd ("Bioretec" or the "Company"), a pioneer in bioabsorbable orthopedic implants, has received 510(k) clearance from... ► Artikel lesen | |
| 13.08. | Bioretec Oy: Bioretec Ltd's Half-year report 2026: H1 close signals momentum | 352 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 13 August 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's half-year report for January-June 2026. The complete half-year report is attached to this... ► Artikel lesen | |
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 05.08. | Bioretec Oy: Panu Mikkonen appointed as Chief Financial Officer of Bioretec | 350 | GlobeNewswire (Europe) | Bioretec Ltd | Company announcement | 5 August 2026 at 4:00 p.m. EESTBioretec Ltd, a pioneer in absorbable orthopedic implants, appoints Panu Mikkonen (M.Sc. Econ) as Chief Financial Officer, effective... ► Artikel lesen | |
| 02.07. | Bioretec Oy: Inside information: Chief Financial Officer Tuukka Paavola will leave the company | 535 | GlobeNewswire (Europe) | Bioretec Ltd, Inside Information, 2 July 2026 at 14.30 EESTBioretec Ltd and Tuukka Paavola have mutually agreed that Paavola will not continue in his position. Paavola will leave his role with immediate... ► Artikel lesen | |
| 17.06. | Bioretec appoints Conan Cavanagh as Head of Research & Development and member of the Management Team | 2 | Cision News | ||
| 17.06. | Bioretec concludes change negotiations | 2 | Cision News | ||
| 04.06. | Bioretec Ltd - Manager's transactions - van Hellenberg Hubar-Fisher | 4 | Cision News | ||
| 02.06. | Bioretec Ltd - Manager's transactions - Jordy Winters | 348 | PR Newswire | TAMPERE, Finland, June 2, 2026 /PRNewswire/ -- Bioretec Oy Company release 2 June 2026 at 13:25 p.m. EEST
Bioretec Oy - Managers' TransactionsPerson subject to the notification requirementName:... ► Artikel lesen | |
| 01.06. | Inside information: Bioretec initiates new change negotiations in production to enhance operational efficiency | 514 | PR Newswire | Bioretec Ltd - Inside information - 1 June 2026 at 19:00 EESTTAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd initiates change negotiations in accordance with the Finnish Act on... ► Artikel lesen | |
| 01.06. | The Board of Directors of Bioretec Ltd resolved on a new stock option plan | 471 | PR Newswire | TAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd Company Announcement -1 June 2026 at 19:05 p.m. EEST
The Board of Directors of Bioretec Ltd has resolved to establish a new... ► Artikel lesen | |
| 15.05. | Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 656 | PR Newswire | TAMPERE, Finland, May 15, 2026 /PRNewswire/ -- Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March... ► Artikel lesen | |
| 15.05. | Bioretec Oy: Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 494 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March 2026. The complete business review is attached to this... ► Artikel lesen | |
| 13.05. | Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 544 | PR Newswire | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EESTHELSINKI, May 13, 2026 /PRNewswire/ -- To be aligned with industry reporting standards, Bioretec will transition to reporting an... ► Artikel lesen | |
| 13.05. | Bioretec Oy: Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 343 | GlobeNewswire (Europe) | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EEST
Bioretec clarifies its 2026-2028 financial target regarding the sales marginTo be aligned with industry reporting standards, Bioretec will... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors | 554 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 20:40 p.m. EEST
Bioretec Ltd's resolutions of the constitutive meeting of the Board of DirectorsAt its... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the Annual General Meeting | 590 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting Bioretec Ltd's Annual General... ► Artikel lesen | |
| 08.05. | Bioretec Oy: Bioretec Ltd's resolutions of the Annual General Meeting | 305 | GlobeNewswire (Europe) | Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting
Bioretec Ltd's Annual General Meeting was held on Friday 8 May 2026 as a hybrid... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,800 | -1,50 % | Eckert&Ziegler vor dem Quartalsbericht: Warum die Aktie wieder Fahrt aufnimmt | ||
| INTUITIVE SURGICAL | 405,40 | -2,97 % | ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising? | ||
| DRAEGERWERK | 103,20 | -1,53 % | Carl Zeiss Meditec, Drägerwerk, Sartorius: Wo Analysten das meiste Potenzial sehen | ||
| INSULET | 131,40 | -5,54 % | Insulet Q3 Net Income Rises; Issues FY26 Outlook | WASHINGTON (dpa-AFX) - Insulet (PODD) reported third quarter net income of $141.1 million, or $2.03 per diluted share, compared to $87.6 million, or $1.24 per diluted share, prior year. Adjusted... ► Artikel lesen | |
| CYTOSORBENTS | 4,980 | +7,33 % | Cytosorbents Corp: CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement | PRINCETON, N.J., Sept. 23, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac... ► Artikel lesen | |
| GENEDX | 62,28 | 0,00 % | GeneDx partners with Mirum for free genetic testing program | ||
| REVENIO GROUP | 10,500 | +0,19 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 19.10.2026 | Folgende Wertpapiere werden in den Handel an der Frankfurter Wertpapierbörse (FWB) aufgenommen.
1. US88025U1097 10X GENOMICS INC
2. NL0000852564 AALBERTS NV
3. SE0016589188 ELECTROLUX AB
4. SE0000115446... ► Artikel lesen | |
| OPTOMED | 1,774 | +19,38 % | Optomed Oyj: Interim report January - September 2026 | Optomed Plc Stock Exchange Release 6 November 2026 at 9.00, Helsinki Optomed Plc: Interim report January - September 2026
July - September 2026
Revenue increased by 17.5 percent to EUR 5.2 (4.4)... ► Artikel lesen | |
| FRESENIUS | 52,48 | +1,18 % | ROUNDUP: Fresenius baut Geschäft mit Nachahmer-Medikamenten aus | BAD HOMBURG (dpa-AFX) - Der Gesundheitskonzern Fresenius baut mit einer Entwicklungsvereinbarung mit dem chinesischen Auftragsforscher und -fertiger WuXi Biologics seine Pipeline von Nachahmermedikamenten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,660 | +0,22 % | EQS-AFR: Siemens Healthineers AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Siemens Healthineers AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Siemens Healthineers AG: Vorabbekanntmachung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,230 | -0,21 % | FMC grenzt Ergebnis-Ausblick für Gesamtjahr 2026 ein | DJ FMC grenzt Ergebnis-Ausblick für Gesamtjahr 2026 ein
Von Britta Becks
DOW JONES--Der Dialysedienstleister Fresenius Medical Care (FMC) hat seinen Ergebnis-Ausblick für das laufende Jahr... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,610 | 0,00 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| PRIVIA HEALTH GROUP | 24,420 | +2,00 % | Privia Health Group, Inc. - 10-Q, Quarterly Report | ||
| BRIGHTSPRING HEALTH SERVICES | 67,13 | +1,93 % | Guggenheim raises BrightSpring Health stock price target on growth | ||
| BILLIONTOONE | 114,01 | +1,44 % | BTIG reiterates Buy on BillionToOne stock, keeps $130 target |